文献速递临床试验与 GCP

英国成人复发性急性扁桃体炎的保守治疗与扁桃体切除术比较(NATTINA):一项多中心、开放标签、随机对照试验

Conservative management versus tonsillectomy in adults with recurrent acute tonsillitis in the UK (NATTINA): a multicentre, open-label, randomised controlled trial.
PubMed 文献 · Lancet · 2023-05-17

这项在英国27家医院开展的多中心开放标签随机对照试验,将453例新转诊的复发性急性扁桃体炎成人随机分为立即扁桃体切除术组(233例)与保守治疗组(220例),主要终点为随机分组后24个月内每周短信报告的咽痛天数。意向性治疗分析显示,立即手术组调整后咽痛总天数的发生率为保守组的0.53倍(95%CI 0.43–0.65;P<0.0001),结论认为立即扁桃体切除术具有临床效果和成本效果。

要点

  • 立即扁桃体切除术组24个月内咽痛中位天数为23天,保守治疗组为30天。
  • 调整部位与基线严重度后,手术组与保守组咽痛总天数发生率比为0.53(95%CI 0.43–0.65;P<0.0001)。
  • 231例手术参与者中90例(39%)共报告191起与扁桃体切除术相关的不良事件,最常见为出血(44例参与者共54起)。

核心结论

  • 与保守治疗相比,立即扁桃体切除术对成人复发性急性扁桃体炎具有临床效果和成本效果。

研究设计与样本

  • 实用性多中心、开放标签、随机对照试验,在英国27家医院开展。
  • 纳入16岁及以上、因复发性急性扁桃体炎新转诊至二级耳鼻喉科门诊的成人。
  • 按1:1随机分配至扁桃体切除术组或保守治疗组,采用可变长度随机排列区组,按招募中心和基线症状严重度(扁桃体结局量表-14评分:轻度0–35、中度36–48、重度49–70)分层。
  • 手术组在随机分配后8周内接受择期扁桃体切除术,保守组在24个月内接受标准非手术治疗。
  • 主要终点为随机分配后24个月内每周短信报告的咽痛天数,主要分析在意向性治疗人群中进行。

主要发现

  • 2015年5月11日至2018年4月30日,4165例复发性急性扁桃体炎患者接受资格评估,3712例被排除,453例合格参与者被随机分配(立即扁桃体切除术组233例 vs 保守治疗组220例)。
  • 429例(95%)患者纳入主要意向性治疗分析(224例 vs 205例)。
  • 参与者中位年龄23岁(IQR 19–30),女性355例(78%),男性97例(21%),大多数为白人(407例[90%])。
  • 立即扁桃体切除术组24个月内咽痛天数少于保守治疗组(中位23天[IQR 11–46] vs 30天[14–65])。
  • 调整中心和基线严重度后,立即扁桃体切除术组(n=224)相比保守治疗组(n=205)咽痛总天数的发生率为0.53(95%CI 0.43–0.65;P<0.0001)。

临床怎么用

  • 原文未据此给出推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tonsillectomy is regularly performed in adults with acute tonsillitis, but with scarce evidence. A reduction in tonsillectomies has coincided with an increase in acute adult hospitalisation for tonsillitis complications. We aimed to assess the clinical effectiveness and cost-effectiveness of conservative management versus tonsillectomy in patients with recurrent acute tonsillitis. METHODS: This pragmatic multicentre, open-label, randomised controlled trial was conducted in 27 hospitals in the UK. Participants were adults aged 16 years or older who were newly referred to secondary care otolaryngology clinics with recurrent acute tonsillitis. Patients were randomly assigned (1:1) to receive tonsillectomy or conservative management using random permuted blocks of variable length. Stratification by recruiting centre and baseline symptom severity was assessed using the Tonsil Outcome Inventory-14 score (categories defined as mild 0-35, moderate 36-48, or severe 49-70). Participants in the tonsillectomy group received elective surgery to dissect the palatine tonsils within 8 weeks after random assignment and those in the conservative management group received standard non-surgical care during 24 months. The primary outcome was the number of sore throat days collected during 24 months after random assignment, reported once per week with a text message. The primary analysis was done in the intention-to-treat (ITT) population. This study is registered with the ISRCTN registry, 55284102. FINDINGS: Between May 11, 2015, and April 30, 2018, 4165 participants with recurrent acute tonsillitis were assessed for eligibility and 3712 were excluded. 453 eligible participants were randomly assigned (233 in the immediate tonsillectomy group vs 220 in the conservative management group). 429 (95%) patients were included in the primary ITT analysis (224 vs 205). The median age of participants was 23 years (IQR 19-30), with 355 (78%) females and 97 (21%) males. Most participants were White (407 [90%]). Participants in the immediate tonsillectomy group had fewer days of sore throat during 24 months than those in the conservative management group (median 23 days [IQR 11-46] vs 30 days [14-65]). After adjustment for site and baseline severity, the incident rate ratio of total sore throat days in the immediate tonsillectomy group (n=224) compared with the conservative management group (n=205) was 0·53 (95% CI 0·43 to 0·65; <0·0001). 191 adverse events in 90 (39%) of 231 participants were deemed related to tonsillectomy. The most common adverse event was bleeding (54 events in 44 [19%] participants). No deaths occurred during the study. INTERPRETATION: Compared with conservative management, immediate tonsillectomy is clinically effective and cost-effective in adults with recurrent acute tonsillitis. FUNDING: National Institute for Health Research.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Wilson JA, O'Hara J, Fouweather T, et al. Conservative management versus tonsillectomy in adults with recurrent acute tonsillitis in the UK (NATTINA): a multicentre, open-label, randomised controlled trial. Lancet. 2023. PMID: 37209706. doi:10.1016/S0140-6736(23)00519-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。